|
Consolidated Statements of Operations (USD $)
In Thousands, except Share data, unless otherwise specified
|
3 Months Ended |
12 Months Ended |
|
Mar. 31, 2012
|
Mar. 31, 2011
|
Dec. 31, 2011
|
Dec. 31, 2010
|
| Revenues: |
|
|
|
|
| License revenue, net |
|
|
$ 0 |
$ 2,125 |
| Grant revenue |
|
|
0 |
489 |
| Total Revenues |
|
|
0 |
2,614 |
| Operating Costs and Expenses: |
|
|
|
|
| General and administrative |
1,468 |
1,233 |
2,588 |
2,117 |
| Research and development |
386 |
231 |
3,340 |
1,580 |
| Total Operating Costs and Expenses |
1,854 |
1,464 |
5,928 |
3,697 |
| Loss from Continuing Operations |
(1,854) |
(1,464) |
(5,928) |
(1,083) |
| Other Income (Expense): |
|
|
|
|
| Warrant expense |
0 |
(716) |
(1,492) |
0 |
| Change in fair value of warrant liability |
0 |
(94) |
(242) |
0 |
| Impairment loss on equipment |
|
|
0 |
(121) |
| Loss on the sale of equipment |
0 |
(5) |
0 |
0 |
| Interest income |
|
|
14 |
0 |
| Other income |
5 |
56 |
22 |
9 |
| Total Other Income (Expense), net |
5 |
(759) |
(1,698) |
(112) |
| Net Loss from Continuing Operations |
(1,849) |
(2,223) |
(7,626) |
(1,195) |
| Net Income (Loss) from Discontinued Operations |
649 |
37 |
(523) |
(516) |
| Net Loss |
$ (1,200) |
$ (2,186) |
$ (8,149) |
$ (1,711) |
| Net Income (Loss) Per Share - Basic and Dilutive: |
|
|
|
|
| Continuing Operations (in dollars per share) |
$ (0.06) |
$ (0.09) |
$ (0.27) |
$ (0.06) |
| Discontinued Operations (in dollars per share) |
$ 0.02 |
$ 0 |
$ (0.02) |
$ (0.02) |
| Net Loss Per Share |
$ (0.04) |
$ (0.09) |
$ (0.29) |
$ (0.08) |
| Weighted average number of common shares outstanding during the year Basic and Dilutive (in shares) |
32,003,164 |
25,220,694 |
27,710,428 |
22,393,568 |